PT Kalbe Farma Tbk. announces an Equity Buyback for 250,000,000 shares, for IDR 250 million.
August 25, 2021 at 12:20 am EDT
Share
Company Name (Ticker) announces a share repurchase program. Under the program, the company will repurchase up to 250,000,000 shares for IDR 250 million. The shares will be repurchased at a price of IDR 250 million. The program will be valid till November 19, 2021.
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
PT KALBE FARMA TBK. 
